FINWIRES · TerminalLIVE
FINWIRES

加拿大帝国商业银行将Winpak的目标股价从52加元下调至47加元,维持其中性评级。

By

-- 在Winpak(WPK.TO)周三公布第一季度业绩后,加拿大帝国商业银行资本市场维持对该公司股票的“中性”评级,并将目标股价从52加元下调至47加元。 “我们维持对Winpak的‘中性’评级,同时将目标股价从52加元下调至47加元,原因是预期下调,且我们将企业价值/息税折旧摊销前利润(EV/EBITDA)估值倍数下调了0.25倍(目前为2027年预期值的6.5倍)。”加拿大帝国商业银行表示,“我们将继续观望,等待美墨加协定(USMCA)续签的前景更加明朗、树脂价格上涨带来的不利影响以及Winpak能否实现可持续的销量增长。” 尽管Winpak没有召开财报电话会议,且该公司“事先准备好的发言稿也相当谨慎”,但加拿大帝国商业银行(CIBC)指出,Winpak的客户出货量在第一季度下半年有所加速增长。CIBC还表示,在与管理层沟通后,其对2026年剩余时间的业绩预测“基本保持乐观”。 CIBC指出:“Winpak公布的EBITDA为5400万美元,远低于我们此前预测的6000万美元和市场普遍预期的5900万美元。调整后的EBITDA利润率为19.2%(CIBC预期为20.5%),同比下降约120个基点。” CIBC补充道,受第一季度业绩不及预期以及下调第二至第四季度利润率预期的影响,CIBC将2026年EBITDA预期下调3%至2.37亿美元,部分被更高的售价所抵消。 CIBC进一步表示,由于销量/利润率假设“小幅下调”,以及预期售价将面临通缩压力,其2027年EBITDA预期下调4%至2.55亿美元。 CIBC补充道:“我们预计2026年销量将增长2.0%(2025年为-1.0%),随着WPK新产能的投产以及在消费品客户中市场份额的提升,2027年增速将加快至4.1%。” 在定价方面,“由于中东冲突导致供应中断,树脂等关键投入品价格面临上涨压力”,CIBC预计2026年同店价格将上涨15%,高于2025年的0.8%,之后随着供应限制的缓解,2027年将面临10%的通缩压力。 加拿大帝国商业银行 (CIBC) 预计,受原材料成本上涨的影响,WPK 2026 年的 EBITDA 利润率平均为 18.0%,随后在 2027 年反弹至 20.5%。 CIBC 指出:“在 2021/2022 年供应链中断以及由此导致的原材料价格通胀压力下,WPK 的 EBITDA 利润率一度降至 16%-19%,这是由于指数化业务的成本转嫁存在滞后性。WPK 约 75% 的业务都采用原材料的合同指数化方案(平均滞后三个月)。”

Price: $39.97, Change: $-0.19, Percent Change: -0.47%

Related Articles

Research

Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.

$BIO
Insider Trading

Comfort Systems USA Insider Sold Shares Worth $889,890, According to a Recent SEC Filing

Pablo G. Mercado, Director, on April 30, 2026, sold 500 shares in Comfort Systems USA (FIX) for $889,890. Following the Form 4 filing with the SEC, Mercado has control over a total of 3,000 common shares of the company, with 3,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035983/000153524626000004/xslF345X05/form4-05012026_040501.xml

$FIX
Insider Trading

Kaiser Aluminum Insider Sold Shares Worth $524,757, According to a Recent SEC Filing

Keith Harvey, Director, President & CEO, on April 29, 2026, sold 3,031 shares in Kaiser Aluminum (KALU) for $524,757. Following the Form 4 filing with the SEC, Harvey has control over a total of 94,308 common shares of the company, with 94,308 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/811596/000119312526201545/xslF345X05/ownership.xml

$KALU